Effective Dosing of Burosumab in XLH | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Effective Dosing of Burosumab in XLH	Bone Diseases, Metabolic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hypophosphatemia, Familial, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Urogenital Diseases, X-linked hypophosphatemic rickets, bone disorder, calcinosis, calcium metabolic disease, hereditary disease, hypophosphatemia, hypophosphatemic rickets, inborn errors of metabolism, inborn metal metabolism disorder, kidney disorder, metabolic disease, musculoskeletal system disorder, nephrocalcinosis, nutritional deficiency disease, nutritional disorder, phosphorus metabolism disease, renal tubular transport disease, rickets, urinary system disorder, vitamin D deficiency, vitamin deficiency disorder	Recruiting	Not stated	2026-05-11		NCT07183579

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Alder Hey Children's NHS Foundation Trust	15
Birmingham Women's and Children's NHS Foundation Trust	13
Manchester University NHS Foundation Trust	41
Newcastle-upon-Tyne Hospitals NHS Trust	24
Nottingham University Hospitals NHS Trust	53
Sheffield Children's NHS Foundation Trust	16
University Hospital Southampton NHS Foundation Trust	59
University Hospitals Bristol and Weston NHS Foundation Trust	15
University of Nottingham	109

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Nottingham University Hospitals NHS Trust	Nottingham	United Kingdom	11